AOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApprovedAOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApproved

Studies

The papers I'm actually reading. Recent research on every compound here, newest first. Read the abstracts before you trust anyone's marketing.

StudyRapid communications in mass spectrometry : RCM · 2026-12-15

Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis

StudyJournal of chromatography. A · 2026-10-11

Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application

StudyCarbohydrate polymers · 2026-10-01

A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing

StudyExperimental eye research · 2026-10-01

Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation

StudyJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026-10-01

Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke

StudyZhonghua xin xue guan bing za zhi · 2026-09-24

[Effects of cardiac rehabilitation and predictive value of Humanin/CRP ratio in patients with acute exacerbation of chronic heart failure]

StudyThe Annals of pharmacotherapy · 2026-09-18

Orforglipron: An Oral GLP-1 Receptor Agonist for Obesity Treatment

StudyPloS one · 2026-09-18

Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model

StudyPostgraduate medicine · 2026-09-18

Plain language review: non-invasive screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in primary care

StudyDiabetologia · 2026-09-18

Unimolecular GLP-1/APJ receptor co-agonism improves metabolism and dyslipidaemia as well as normalising hepatic triglyceride and aminotransferase elevation in high-fat-fed mice

StudyJournal of molecular histology · 2026-09-18

Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice

StudyJCEM case reports · 2026-09-17

Simultaneous and recurrent hordeola and chalazia associated with tirzepatide therapy: a case series

StudyChildhood obesity (Print) · 2026-09-17

Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists

StudyJCEM case reports · 2026-09-16

Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome

StudyNature metabolism · 2026-09-15

Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats

StudyJournal of bioenergetics and biomembranes · 2026-09-14

Mitokines as bioenergetic stress signals in cardiovascular disease: mitochondrial communication, endocrine adaptation, and translational implications

StudyTherapeutic advances in endocrinology and metabolism · 2026-09-11

Assessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic

StudyEndocrine journal · 2026-09-11

Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests

StudyTissue & cell · 2026-09-10

Ghrelin attenuates hypoxia-induced mitochondrial oxidative stress damage in HTR-8/SVneo trophoblasts

StudyScientific reports · 2026-09-09

Correction: Reduced serum and skeletal muscle MOTS c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction

StudyThe Cochrane database of systematic reviews · 2026-09-09

Thymosin-ɑ1 for people with chronic hepatitis B

StudyCardiovascular drugs and therapy · 2026-09-08

Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue

StudyWorld journal of gastrointestinal pharmacology and therapeutics · 2026-09-05

Emerging antimicrobial peptides in gastrointestinal disorders: Dual role in immunity and therapy

StudyAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026-09-03

Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis